Professional Documents
Culture Documents
NYSE HOLD Fundamental research indicates a 1% upside in the NYSE common stock over the next 6-24 months.
Direct access to
We have calculated the the
targetfull
pricereport
based onfree of charge
fundamental factors,at
using a weighted average of target
Common http://www.iirgroup.com/researchoracle/viewreport/show/20295
prices obtained using DCF and comparative valuation methodologies.
Stock
Ticker: COV
Target price: US$49.37
Current price: US$48.96 We reiterate the NYSE common stock a HOLD rating with a 6-24 month target price of US$49.37 per
share.
European BUY The European stock is expected to appreciate 21% over the next 6-24 months as the 1% fundamental
upside is augmented by 18 percentage points upside attributable to the anticipated appreciation of
Stock1 the USD against the Euro over the same period is further augmented by 2 percentage points upside
attributable to the anticipated reduction in the European stock discount2 over the same period. We
revert to a 6-24 month horizon as we now expect a significant currency impact on the European stock
over 6-24 months3.
Ticker: COV.F
Target price: €36.14
Current price: €29.96 We upgrade the European stock rating for Covidien from a SELL to a BUY with a 6-24 month target
price of US$36.14 per share.